Replies to post #39459 on Cytodyn Inc (CYDY)

[ClosetInvestor]

Like you and others have said, revenue from the licensing of leronlimab may support CYDY going it alone for cancer indications. If the drug works for cancer, that would be hugely profitable.

The Prostagene test should also bring in revenue that could fund CYDY going it alone for cancer.

[Fortuno]

I don’t feel patronized at all. No worries.

I would not feel comfortable about NP being the captain of that ship.
I prefer getting less while L is in the hands of experienced people knowing what they’re doing.

[Blueheel1]

Great post - thanks as always for the thoughtful write-ups.